M&G

Udaan operates as a comprehensive B2B e-commerce platform in India, connecting businesses with suppliers across various sectors, including FMCG, pharmaceuticals, and staples. The platform addresses key trade challenges faced by small, medium, and large enterprises by enabling direct connections for better deals. Udaan facilitates the buying and selling process through secure payment options and efficient logistics, allowing retailers and businesses to source products from manufacturers, brands, white labels, and importers all in one place. Additionally, Udaan provides financial products to support small businesses, thereby streamlining supply chain operations and enhancing overall efficiency in the marketplace.

SeQura is a Barcelona-based company founded in 2013 that specializes in eCommerce payment solutions designed to enhance conversion rates and ensure secure transactions for retailers. The company provides a variety of payment methods, including immediate payment options and flexible plans such as "Buy Now Pay Later" and installment payments. SeQura's platform incorporates innovative risk scoring to improve credit access for underserved customers, catering to various sectors by offering tailored solutions that enhance customer acquisition, conversion, and retention. By focusing on user-friendly payment experiences, SeQura enables businesses to optimize sales performance while appealing to value-conscious shoppers.

BauMont is a real estate private equity investment firm that offers investment management services.

Nuclera specializes in providing a protein prototyping system designed to enhance drug discovery by making proteins readily accessible to researchers. The company's eProtein Discovery system enables scientists to quickly produce and evaluate proteins, thus accelerating their research efforts. Nuclera's automated platform delivers reliable, high-quality, and soluble proteins within a specified timeframe, facilitating the scale-up of protein projects. The integration of technology, including cell-free protein synthesis and digital microfluidics on smart cartridges, allows for efficient, high-throughput access to proteins. This streamlined approach supports researchers in advancing their protein projects more rapidly and effectively.

Apollo Therapeutics is a biopharmaceutical company based in Cambridge, United Kingdom, that collaborates with three leading UK universities—Imperial College London, University College London, and the University of Cambridge—and three major pharmaceutical companies. The company focuses on translating groundbreaking medical research into effective therapeutics, facilitating the development of pre-clinical and clinical-stage assets. Apollo Therapeutics manages a venture capital fund that provides financial and technical support for innovative projects sourced from top British academic research, with a particular emphasis on areas such as oncology, major inflammatory disorders, and rare diseases. By leveraging its experienced team of industry scientists, Apollo aims to optimize therapeutic delivery and enhance patient treatments and outcomes, establishing a strong link between academia and the pharmaceutical industry to foster impactful medical advancements.

Udaan operates as a comprehensive B2B e-commerce platform in India, connecting businesses with suppliers across various sectors, including FMCG, pharmaceuticals, and staples. The platform addresses key trade challenges faced by small, medium, and large enterprises by enabling direct connections for better deals. Udaan facilitates the buying and selling process through secure payment options and efficient logistics, allowing retailers and businesses to source products from manufacturers, brands, white labels, and importers all in one place. Additionally, Udaan provides financial products to support small businesses, thereby streamlining supply chain operations and enhancing overall efficiency in the marketplace.

Apollo Therapeutics is a biopharmaceutical company based in Cambridge, United Kingdom, that collaborates with three leading UK universities—Imperial College London, University College London, and the University of Cambridge—and three major pharmaceutical companies. The company focuses on translating groundbreaking medical research into effective therapeutics, facilitating the development of pre-clinical and clinical-stage assets. Apollo Therapeutics manages a venture capital fund that provides financial and technical support for innovative projects sourced from top British academic research, with a particular emphasis on areas such as oncology, major inflammatory disorders, and rare diseases. By leveraging its experienced team of industry scientists, Apollo aims to optimize therapeutic delivery and enhance patient treatments and outcomes, establishing a strong link between academia and the pharmaceutical industry to foster impactful medical advancements.

Bluejay Mining plc is focused on the exploration and development of precious and base metals, primarily in Greenland, Finland, and the United Kingdom. The company is advancing its flagship Dundas ilmenite project in Greenland, which is recognized as the highest-grade mineral sand ilmenite project globally. This project has significant expansion potential, with only a fraction of the raised beach area assessed, indicating the scale of the deposit is still emerging. In addition to ilmenite, Bluejay Mining explores for various metals, including copper, cobalt, zinc, nickel, gold, lead, titanium, and silver. The company is also involved in other projects such as Kangerluarsuk, Disko-Nuussuaq, and Thunderstone. Established in 2005 and headquartered in London, Bluejay Mining was formerly known as FinnAust Mining Plc before rebranding in 2017.

Teylor AG has developed one of the fastest and most comfortable SME loans in Germany. Using a self-built application and underwriting process, applicants can get a credit offer in less than 10 minutes and receive a business loan of up to €250,000 in two days. Users only need to fill out a simple form on the Teylor website. Teylor then analyzes a large variety of different data points from various sources to review the applicant and generate an offer within seconds. The user can conduct every step directly on the Teylor website. Teylor is partnering with a variety of different manufacturers, brokers, and financial advisors and enables them to provide Teylor-loans to their customers. In the long term, Teylor’s goal is to license the processes and technologies it has built for the Teylor-loan to different financial institutions. By partnering with Teylor, banks can automate their small ticket SME lending processes and drastically reduce their underwriting and administration costs.

Ascentric is a digital wrap and wealth management platform for advisers with assets under administration.